Acta Pharmacologica Sinica 2008 February; 29 (2): 278-284; doi: 10.1111/j.1745-7254.2008.00737.x

 
Original Article
[ Full text ]
 
Discovery of a novel competitive inhibitor of PTP1B by high-throughput screening1
 

Lei SHI2,3, Hai-ping YU2,3, Yue-yang ZHOU2, Jun-qin DU2, Qiang SHEN2, Jing-ya LI2, Jia LI2,4

2National Center for Drug Screening, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201203, China

 

Aim: To characterize the functional and pharmacological features of agonist-induced hump currents in human α4β2-nicotinic acetylcholine receptors (nAChR).

 

Results: HTS was finished with an averaged Z´ factor of 0.63, and LGH00081, a competitive inhibitor of PTP1B with novel structure and relatively good selectivity for receptor-type protein tyrosine phosphatases, was identified.


Conclusion:
We established a molecular level assay which is useful for the screening of PTP1B inhibitors with therapeutic potential. The novel competitive PTP1B inhibitor LGH00081 offers a good start for structure modification and cellular functional activity study.

 

Keywords: high throughput screening; PTP1B; insulin receptor; phosphoryaltion; competitive inhibitor

 
1 Project supported by National Natural Science Foundation of China grants (No 30623008, 30200341, and 30400560) and a Shanghai Commission of Science and Technology grant (No 054319910).

3 These authors contributed equally to this work.
4 Correspondence to Prof Jia LI.
Phn 86-21-5080-1313.
Fax 86-21-5080-1552.
E-mail jli@mail.shcnc.ac.cn
Received 2007-05-13     Accepted 2007-08-31

[ Full text ]
 

Copyright©APS 2009
Add: 294 Tai-Yuan Road, Shanghai 200031, China
Phn: 86-21-5492-2821  Fax: 86-21-5492-2823
E-mail: aps@mail.shcnc.ac.cn